| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |